載入...
Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway
In our previous study, cardiac glycosides including bufalin, a group of sodium pump (Na+/K+-ATPase) inhibitors widely used to treat heart failure for many years, have been demonstrated to induce a delay of mitotic entry and mitotic arrest in many cancer cells. However, the underlying mechanism remai...
Na minha lista:
發表在: | Oncotarget |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Impact Journals LLC
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5862615/ https://ncbi.nlm.nih.gov/pubmed/29568394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24475 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|